Palvella Therapeutics (PVLA) Short Interest Ratio & Short Volume

Short interest is the volume of Palvella Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,978,927 shares of PVLA short. 17.39% of Palvella Therapeutics' shares are currently sold short. Learn More on Palvella Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PVLA shares currently have a short interest ratio of 8.2. Learn More on Palvella Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Palvella Therapeutics: Caption Management LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.39% of Palvella Therapeutics' floating shares are currently sold short.

Palvella Therapeutics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,978,927 shares, a decline of 9.1% from the previous total of 2,176,586 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

17.39% of Palvella Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Palvella Therapeutics: ImmunityBio, Inc. (44.72%), Qiagen N.V. (3.10%), Arcellx, Inc. (3.36%), Kymera Therapeutics, Inc. (14.03%), Belite Bio, Inc. Sponsored ADR (3.22%), Protagonist Therapeutics, Inc. (13.84%), Cogent Biosciences, Inc. (8.00%), Terns Pharmaceuticals, Inc. (10.72%), Mirum Pharmaceuticals, Inc. (15.89%), Centessa Pharmaceuticals PLC Sponsored ADR (2.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

Short selling PVLA is an investing strategy that aims to generate trading profit from Palvella Therapeutics as its price is falling. PVLA shares are trading up $1.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Palvella Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PVLA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVLA, twice per month. The most recent reporting period available is April, 15 2026.